122 related articles for article (PubMed ID: 2141511)
21. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
[TBL] [Abstract][Full Text] [Related]
22. [Effect of blood transfusion on prognosis of colorectal cancer patients].
Onodera H; Maetani S; Tobe T
Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1890-8. PubMed ID: 2608018
[TBL] [Abstract][Full Text] [Related]
23. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma.
Purdie CA; Piris J
Histopathology; 2000 Feb; 36(2):121-6. PubMed ID: 10672056
[TBL] [Abstract][Full Text] [Related]
24. Blood transfusion and recurrence of colorectal cancer.
Modin S; Karlsson G; Wählby L; Wählby L
Eur J Surg; 1992; 158(6-7):371-5. PubMed ID: 1356471
[TBL] [Abstract][Full Text] [Related]
25. Blood transfusions and prognosis in colorectal cancer: long-term results of a randomized controlled trial.
Harlaar JJ; Gosselink MP; Hop WC; Lange JF; Busch OR; Jeekel H
Ann Surg; 2012 Nov; 256(5):681-6; discussion 686-7. PubMed ID: 23095610
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
27. Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer.
Carpelan-Holmström M; Haglund C; Lundin J; Järvinen H; Roberts P
Eur J Cancer; 1996 Jun; 32A(7):1156-61. PubMed ID: 8758246
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of mucinous component in colorectal carcinoma.
Papadopoulos VN; Michalopoulos A; Netta S; Basdanis G; Paramythiotis D; Zatagias A; Berovalis P; Harlaftis N
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s123-5. PubMed ID: 15655594
[TBL] [Abstract][Full Text] [Related]
29. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.
Cianchi F; Palomba A; Boddi V; Messerini L; Pucciani F; Perigli G; Bechi P; Cortesini C
World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379
[TBL] [Abstract][Full Text] [Related]
30. Factors predictive of survival in patients with node-positive colorectal cancer in Taiwan.
Wang WS; Chen PM; Chiou TJ; Liu JH; Fan FS; Lin TC; Jiang JK; Yang SH; Yen CC; Wang HS; Lin JK
Hepatogastroenterology; 2000; 47(36):1590-4. PubMed ID: 11149009
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of smoking in addition to established risk factors in patients with Dukes B and C colorectal cancer: a retrospective analysis.
Diamantis N; Xynos ID; Amptulah S; Karadima M; Skopelitis H; Tsavaris N
J BUON; 2013; 18(1):105-15. PubMed ID: 23613395
[TBL] [Abstract][Full Text] [Related]
32. Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer.
Edna TH; Bjerkeset T
Dis Colon Rectum; 1998 Apr; 41(4):451-9. PubMed ID: 9559629
[TBL] [Abstract][Full Text] [Related]
33. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease.
Evans MD; Barton K; Rees A; Stamatakis JD; Karandikar SS
Colorectal Dis; 2008 Feb; 10(2):157-64. PubMed ID: 17477849
[TBL] [Abstract][Full Text] [Related]
34. Recurrence and survival after potentially curative surgery for colorectal cancer.
Jadallah F; McCall JL; van Rij AM
N Z Med J; 1999 Jul; 112(1091):248-50. PubMed ID: 10448981
[TBL] [Abstract][Full Text] [Related]
35. Preoperative anaemia and perioperative red blood cell transfusion as prognostic factors for recurrence and mortality in colorectal cancer-a Swedish cohort study.
Mörner ME; Edgren G; Martling A; Gunnarsson U; Egenvall M
Int J Colorectal Dis; 2017 Feb; 32(2):223-232. PubMed ID: 27770250
[TBL] [Abstract][Full Text] [Related]
36. Different distribution of Dukes' stage between proximal and distal colorectal cancer.
Ikeda Y; Akagi K; Kinoshita J; Abe T; Miyazaki M; Mori M; Sugimachi K
Hepatogastroenterology; 2002; 49(48):1535-7. PubMed ID: 12397728
[TBL] [Abstract][Full Text] [Related]
37. Correlation between postoperative infections and long-term survival after colorectal resection for cancer.
Nespoli A; Gianotti L; Totis M; Bovo G; Nespoli L; Chiodini P; Brivio F
Tumori; 2004; 90(5):485-90. PubMed ID: 15656334
[TBL] [Abstract][Full Text] [Related]
38. Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients.
Diep CB; Thorstensen L; Meling GI; Skovlund E; Rognum TO; Lothe RA
J Clin Oncol; 2003 Mar; 21(5):820-9. PubMed ID: 12610180
[TBL] [Abstract][Full Text] [Related]
39. Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer.
Petersen VC; Baxter KJ; Love SB; Shepherd NA
Gut; 2002 Jul; 51(1):65-9. PubMed ID: 12077094
[TBL] [Abstract][Full Text] [Related]
40. The influence of blood transfusions upon the recurrence rate of colorectal cancer.
Kjems E; Schydlowski P; Søndergaard JO
Rev Med Chir Soc Med Nat Iasi; 1991; 95(3-4):265-8. PubMed ID: 1823443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]